Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study.
肿瘤科
队列
人口
危险系数
作者
Husam Abdel-Qadir,Nasruddin Sabrie,Darryl P. Leong,Andrea Pang,Peter C. Austin,Anca Prica,Kumaraswamy Nanthakumar,Oscar Calvillo-Argüelles,Douglas S. Lee,Paaladinesh Thavendiranathan
PURPOSEIbrutinib reduces mortality in chronic lymphocytic leukemia (CLL). It increases the risk of atrial fibrillation (AF) and bleeding and there are concerns about heart failure (HF) and central ...
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
cdercder
东方元语
柏柏
Kao
伶俐妙海
Nexus
传统的故事
arniu2008
Nole
无极微光
OK
核桃
Criminology34
zho
初景
sagitar
GingerF
俭朴的甜瓜
柑橘乌云
皖公网安备34019202002308
